Products & Reviews

GenScript ReadyEdit LNP solutions are designed to support efficient delivery of gene editing payloads for research applications, including CRISPR-based genome editing and in vivo gene editing studies. By combining optimized lipid nanoparticle (LNP) formulations with pre-validated editing components, GenScript helps simplify and accelerate gene editing workflow development.

Scar by PIE, Scarless by PIE, Scarless by T4—Tailored for Your Research Needs. Our Custom Circular RNA (circRNA) Synthesis Service delivers high-purity, stable, and efficient RNA solutions for research and therapeutic applications. Choose from circRNA with Scar by PIE, Scarless circRNA by PIE, and Scarless circRNA by T4 Ligation for tailored performance in gene therapy, protein translation, and biomarker discovery.

Guaranteed application in immunoassay development for PK and ADA analysis

70+ different formats of bsAb produced; 5,000+ bsAb projects delivered; 6+ optimized processes provided

Accelerate precision gene editing with GenScript's customized synthetic sgRNA, up to 266 nt in length.

Accelerate precision gene editing with GenScript's customized HDR Knock-in Templates, available in three versatile formats.

Confidently transition your CRIPSR-based cell or gene therapy from bench to clinic with cGMP (current Good Manufacturing Practice) gRNA.

Advance to IND filing and clinical trials faster and more efficiently with cGMP (current Good Manufacturing Practice) HDR Knock-in Templates, available in three versatile formats.

Unlock prolonged and enhanced gene expression with GenScript’s self-amplifying RNA (saRNA) solutions. Our ready-to-use saRNA is ideal for vaccine development, immunization applications. With rapid turnaround times and scalable production, GenScript delivers high-quality saRNA tailored to your needs.

Extend automation and performance for Volatile Organic Compounds (VOC) in water by HS-GC-MS analysis, enhancing productivity in compliance with regulatory requirements.

Envisia is a droplet-based single-cell platform that overcomes Poisson limitations to enable deterministic cell handling, sequential droplet merging, and iterative assays, unlocking true functional, phenotypic screening at the single-cell level.

Vacuum controller

Line probe assay, based on the reverse hybridization principle, designed for the identification of 32 different genotypes of the human papillomavirus (HPV).

Qualitative detection of promotor hypermethylation of 2 cervical cancer associated genes (FAM19A4 and hsa-miR124-2). Identify HPV positive women with high short-term progression to (pre)cancer.

Qualitative detection of 14 high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, 68) as well as putative HPV high risk type 67, with separate identification of HPV16 and 18 in one test. Fully clinically validated HPV screening method to identify women at risk for cervical (pre)cancer using either cervical scrape or self-collected vaginal sample.

Qualitative detection of 15 High-Risk HPV types with simultaneous genotyping of HPV16 and 18 in one tube. Fast. Simple. Accurate.

Qualitative detection and identification of 15 High-Risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. Fast. Simple. Accurate.

PreCursor-M AnoGYN is a methylation-specific molecular assay to detect promoter hypermethylation of the human genes ASCL1 and ZNF582  in bisulfite-converted DNA prepared from human samples, for instance formalin-fixed paraffin embedded anal biopsies or anal swab specimens.

Immunoassay to be used with the automated LUMIPULSE G System for the quantitative measurement of neurofilament light (NfL) in human plasma and serum. 

Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human K2EDTA plasma. 

Immunoassay to be used with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 181 (pTau 181) in human plasma.

Immunoreaction cartridges to be used with the automated LUMIPULSE G System for the quantitative measurement of β-amyloid1-40 in human plasma.

Reliable mixing and piercing for consistent blood sampling

CIMmultus Oligo dT monolithic columns use hybridization affinity chromatography and an immobilized oligo-deoxythymidilic acid (oligo dT) ligand

Assay (Titration): 98.0 - 102.0 %